News
October 25, 2012
EarlySense aims for $100 million in sales
July 31, 2012
The IUB™, a Breakthrough IUD from OCON Medical is in Human Clinical Trials
May 1, 2012
Pfizer and Protalix BioTherapeutics Announce FDA Approval of ELELYSO. (taliglucerase alfa) for the Treatment of Gaucher Disease
March 14, 2012
X-Sight Systems Automated FOD Detection System - to Keep Ultimate Safety in Bangkok's Suvarnabhumi International Airport's Runways
February 1, 2012
GE healthymagination Fund invests in Check-Cap Ltd., developer of
ingestible imaging capsule that could detect colorectal cancer
September 6, 2011
Aposense Cancer Drug Demonstrates 100% Oral Bioavailability in New Study
August 17, 2011
Protalix expects FDA answer on Gaucher's drug in February
May 2011
The Israel Airports Authority and X-Sight Systems sign a major contract to equip Ben-Gurion International Airport with an Automated Foreign Object Debris (FOD) Detection System
May 25, 2011
United Medical Systems Partners With IceCure For Treatment Of Fibroadenoma
April 27, 2011
Wound cure co MacroCure raises $13m
November 8, 2010
Roche to Use Aposense EarliTest™ for Imaging of Apoptosis in Oncology Clinical Trials
June 7, 2010
Aposense gains high valuation in successful IPO
June 6, 2010
Web search co SimilarGroup raises $1m
June 3, 2010
Patent monitor co EarlySense raises $13m
May 31, 2010
SimilarWeb Changes Name To SimilarGroup, Raises More Funding
May 31, 2010
Aposense chalks up success in institutional tender
May 23, 2010
Biotech co Aposense raises $3m ahead of IPO
January 20, 2010
Plant collagen co CollPlant wins EU funding
December 1, 2009
Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
November 15, 2009
CollPlant signs Japan distribution deal
October 15, 2009
Protalix BioTherapeutics Announces Positive Top-line Results from its Phase III Clinical Trial of UPLYSO(TM) for the Treatment of Gaucher Disease
September 21, 2009
IBA and APOSENSE sign strategic collaboration to commercialize
APOSENSE® ML-10 for molecular imaging of apoptosis
September 14, 2009
Protalix Completes Pivotal Phase III Trial for prGCD for the Treatment of Gaucher Disease
September 8, 2009
FDA Grants Protalix Orphan Drug Designation for prGCD
August 26, 2009
Thales and Xsight form strategic partnership to reduce foreign object damage to aircraft
August 17, 2009
U.S. Food and Drug Administration Approves Protalix's Treatment Protocol for prGCD
July 12, 2009
Protalix Approached by the FDA to Consider Submitting a Treatment Protocol for the Use of prGCD in Patients with Gaucher Disease Allowing Expanded Access to prGCD
June 2009
Yissum Licenses to Van Leer Ventures a Software Platform for Maximizing PC Processing Power
March 30, 2009
Xsight Enters Distribution and Product Integration Agreement with SAIC
March 11, 2009
Protalix BioTherapeutics Receives Research Grant of over $6 Million from the Israeli Government’s Office of the Chief Scientist
March 4, 2009
Medical device co EarlySense
raises $2m
March 2, 2009
EarlySense to Partner
With Catholic Healthcare West in Evaluating Patient Health With the
EverOn® Patient Supervision
System
February 24, 2009
Elbit Systems completes acquisition of
Shiron Satellite Communications for $16
Million
January 8, 2009
Elbit Systems Signs Share Purchase Agreement Regarding Purchase Offer to
Shareholders of Shiron Satellite Communications Ltd.
December 22, 2008
St. Jude Medical Acquires MediGuide
December 19, 2008
Protalix BioTherapeutics Announces First Patient Enrolled in Open-Label, Switchover Trial of prGCD for the Treatment of Gaucher Disease
December 15, 2008
Teva invests in yeast-based drug discovery co Jexys
December 9, 2008
Van Leer: The Roots of the Technology Incubator
Grew from a Traveling Circus during the Days of World War II
December 2, 2008
Protalix BioTherapeutics Announces Completion of Enrollment for its Pivotal Phase III Clinical Trial of Gaucher Disease
August 20, 2008
NST NeuroSurvival Technologies Completes $13.3 Million Financing, Changes
Name to Aposense Ltd.
July 23, 2008
APOSENSER [18F]-ML-10 for Molecular Imaging of Apoptosis to Proceed to Phase
I/II Trials
July 1, 2008
Arbel Medical has completed a $4.5 million round of capital raising
June 26, 2008
MediGuide and Asahi Intecc team on surgical guide wire
May 23, 2008
F.A.A. Tests Ways to Detect Runway Junk
May 5, 2008
EarlySense Is Selected to Exhibit at the “Facing Tomorrow: the Israel Presidential Conference 2008” Marking Israel’s 60th Birthday
April, 2008
CollPlant Successfully Raised $ 8.35 Million
March 20, 2008
Spectronix Wins More Contracts from U.S. Army
March 18, 2008
"Computer for Every Child" Company Fourier raises $3.5m
January 23, 2008
MediGuide Signs Collaboration Agreement for Navigational Products with Medtronic
November 20, 2007
EarlySense Receives FDA Clearance for Its Contact-Free Patient's Clinical Status Monitor
October 25, 2007
Protalix (AMEX:PLX) has Raised $50 million in Secondary Offering
September 3, 2007
CogniTens Acquired by Hexagon, Global Metrology Market Leader, Joins Largest Industrial Measurement Group
May 28, 2007
MentorWave closes second financing round
April 11, 2007
CollPlant raises $4.5 million
March 11, 2007
Protalix BioTherapeutics, Inc. to Commence Trading on the American Stock Exchange
December 7, 2006
Secure Islands Technologies raises $1.1m in first round
November 28, 2006
EarlySense completed $4.8 Million Series B Investment Round
November 28, 2006
EarlySense completed $4.8 Million Series B Investment Round
November 20, 2006
NST Completes Financing by US Investors, Following Successful Commencement of Clinical Efficacy Studies in Molecular Imaging of Cell Death
November 7, 2006
Month-old startup OriginGPS scores $0.9 million in first round
June 21, 2006
Medical device company CritiSense raise $1.2
|
